Earnings History Data for Armata Pharmaceuticals, Inc. (ARMP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
07-05-2024 | AH | ARMP | Armata Pharmaceuticals | 90.00 | -0.69 | -0.28 | 0.00 | Armata Pharmaceuticals GAAP EPS of -$0.69 misses by $0.38, revenue of $0.97M misses by $0.17M [5/7/2024 6:29 PM] |
2.83 | -0.03 (-1.05%) |
0.0 | 0.0 (0.00%) |
1.07 - 5.26 | 5,809 | 10,000 | 0 | ||
14-11-2023 | AH | ARMP | Armata Pharmaceuticals | 93.00 | -0.31 | -0.33 | 0.00 | Armata Pharmaceuticals GAAP EPS of -$0.86, revenue of $1.2M [11/14/2023 5:11 PM] |
2.24 | -0.44 (-16.42%) |
2.47 | -0.21 (-7.84%) |
0.83 - 5.26 | 35,679 | 10,000 | 172 | ||
14-08-2023 | PM | ARMP | Armata Pharmaceuticals | 146.00 | -0.28 | -0.35 | 0.00 | Armata Pharmaceuticals GAAP EPS of -$0.17, revenue of $0.98M [8/14/2023 9:41 AM] |
4.15 | -0.20 (-4.60%) |
0.0 | 0.0 (0.00%) |
0.83 - 5.26 | 268,796 | 140,000 | 0 | ||
10-11-2021 | AH | ARMP | Armata Pharmaceuticals | 95.00 | -0.22 | -0.26 | 0.00 | Armata Pharmaceuticals EPS beats by $0.04, beats on revenue [11/10/2021 4:58 PM] |
3.36 | -0.27 (-7.44%) |
3.36 | -0.27 (-7.44%) |
2.56 - 10.48 | 5,683 | 90,000 | 1,002 | ||
13-05-2021 | AH | 4:05 PM ET (May 13) |
ARMP | Armata Pharmaceuticals, Inc. | 101.26 | -0.27 | -0.28 | -0.49 | Armata Pharmaceuticals EPS beats by $0.05 [5/13/2021 5:18 PM] |
3.92 | 0.03 (0.77%) |
0.0 | 0.0 (0.00%) |
2.56 - 10.48 | 3,795 | 10,000 | 0 | |
|
||||||||||||||||||
18-03-2021 | AH | 4:05 PM ET (Mar 18) |
ARMP | Armata Pharmaceuticals, Inc. | 114.17 | -0.36 | 0.00 | -0.48 | Armata Pharmaceuticals EPS misses by $0.08, beats on revenue [3/18/2021 4:31 PM] |
5.49 | 0.03 (0.55%) |
6.29 | 0.78 (14.16%) |
2.56 - 10.48 | 16,267 | 30,000 | 9,314 | |
|